Targeting the alternative NF-κB pathway in pancreatic cancer: a new direction for therapy?

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

This work was supported by R21-CA135102 and R01-CA140182 from the NIH and an AACR grant (08-20-25-STOR), all to P Storz. The author thanks the Pancreatic Cancer Action Network (PanCAN) and the Patty Boshell Pancreatic Cancer Foundation for their support. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.